Cardiome enters development agreement with Eddingpharm for BrinavessTM in China
Cardiome announced an agreement with Eddingpharm to develop and commercialize BRINAVESS™ in China, Taiwan, and Macau and re-launch BRINAVESS in Hong Kong. Eddingpharm is responsible for clinical trials and regulatory approvals required to commercialize BRINAVESS in the target countries. December 19, 2014